The development of DNA vaccines against SARS-CoV-2
Background The COVID-19 pandemic exerted significant impacts on public health and global economy. Research efforts to develop vaccines at warp speed against SARS-CoV-2 led to novel mRNA, viral vectored, and inactivated vaccines being administered. The current COVID-19 vaccines incorporate the full...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Published: |
Elsevier
2023
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2825/ https://doi.org/10.1016/j.advms.2023.05.003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Sunway University |
id |
my.sunway.eprints.2825 |
---|---|
record_format |
eprints |
spelling |
my.sunway.eprints.28252024-07-16T01:53:21Z http://eprints.sunway.edu.my/2825/ The development of DNA vaccines against SARS-CoV-2 Kanwal, Khalid * Poh, Chit Laa * QR Microbiology RA Public aspects of medicine RM Therapeutics. Pharmacology Background The COVID-19 pandemic exerted significant impacts on public health and global economy. Research efforts to develop vaccines at warp speed against SARS-CoV-2 led to novel mRNA, viral vectored, and inactivated vaccines being administered. The current COVID-19 vaccines incorporate the full S protein of the SARS-CoV-2 Wuhan strain but rapidly emerging variants of concern (VOCs) have led to significant reductions in protective efficacies. There is an urgent need to develop next-generation vaccines which could effectively prevent COVID-19. Methods PubMed and Google Scholar were systematically reviewed for peer-reviewed papers up to January 2023. Results A promising solution to the problem of emerging variants is a DNA vaccine platform since it can be easily modified. Besides expressing whole protein antigens, DNA vaccines can also be constructed to include specific nucleotide genes encoding highly conserved and immunogenic epitopes from the S protein as well as from other structural/non-structural proteins to develop effective vaccines against VOCs. DNA vaccines are associated with low transfection efficiencies which could be enhanced by chemical, genetic, and molecular adjuvants as well as delivery systems. Conclusions The DNA vaccine platform offers a promising solution to the design of effective vaccines. The challenge of limited immunogenicity in humans might be solved through the use of genetic modifications such as the addition of nuclear localization signal (NLS) peptide gene, strong promoters, MARs, introns, TLR agonists, CD40L, and the development of appropriate delivery systems utilizing nanoparticles to increase uptake by APCs in enhancing the induction of potent immune responses. Elsevier 2023 Article PeerReviewed Kanwal, Khalid * and Poh, Chit Laa * (2023) The development of DNA vaccines against SARS-CoV-2. Advances in Medical Sciences, 68 (2). pp. 213-226. ISSN 1898-4002 https://doi.org/10.1016/j.advms.2023.05.003 10.1016/j.advms.2023.05.003 |
institution |
Sunway University |
building |
Sunway Campus Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Sunway University |
content_source |
Sunway Institutional Repository |
url_provider |
http://eprints.sunway.edu.my/ |
topic |
QR Microbiology RA Public aspects of medicine RM Therapeutics. Pharmacology |
spellingShingle |
QR Microbiology RA Public aspects of medicine RM Therapeutics. Pharmacology Kanwal, Khalid * Poh, Chit Laa * The development of DNA vaccines against SARS-CoV-2 |
description |
Background
The COVID-19 pandemic exerted significant impacts on public health and global economy. Research efforts to develop vaccines at warp speed against SARS-CoV-2 led to novel mRNA, viral vectored, and inactivated vaccines being administered. The current COVID-19 vaccines incorporate the full S protein of the SARS-CoV-2 Wuhan strain but rapidly emerging variants of concern (VOCs) have led to significant reductions in protective efficacies. There is an urgent need to develop next-generation vaccines which could effectively prevent COVID-19.
Methods
PubMed and Google Scholar were systematically reviewed for peer-reviewed papers up to January 2023.
Results
A promising solution to the problem of emerging variants is a DNA vaccine platform since it can be easily modified. Besides expressing whole protein antigens, DNA vaccines can also be constructed to include specific nucleotide genes encoding highly conserved and immunogenic epitopes from the S protein as well as from other structural/non-structural proteins to develop effective vaccines against VOCs. DNA vaccines are associated with low transfection efficiencies which could be enhanced by chemical, genetic, and molecular adjuvants as well as delivery systems.
Conclusions
The DNA vaccine platform offers a promising solution to the design of effective vaccines. The challenge of limited immunogenicity in humans might be solved through the use of genetic modifications such as the addition of nuclear localization signal (NLS) peptide gene, strong promoters, MARs, introns, TLR agonists, CD40L, and the development of appropriate delivery systems utilizing nanoparticles to increase uptake by APCs in enhancing the induction of potent immune responses. |
format |
Article |
author |
Kanwal, Khalid * Poh, Chit Laa * |
author_facet |
Kanwal, Khalid * Poh, Chit Laa * |
author_sort |
Kanwal, Khalid * |
title |
The development of DNA vaccines against SARS-CoV-2 |
title_short |
The development of DNA vaccines against SARS-CoV-2 |
title_full |
The development of DNA vaccines against SARS-CoV-2 |
title_fullStr |
The development of DNA vaccines against SARS-CoV-2 |
title_full_unstemmed |
The development of DNA vaccines against SARS-CoV-2 |
title_sort |
development of dna vaccines against sars-cov-2 |
publisher |
Elsevier |
publishDate |
2023 |
url |
http://eprints.sunway.edu.my/2825/ https://doi.org/10.1016/j.advms.2023.05.003 |
_version_ |
1805893818474561536 |